These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22088983)

  • 21. Changes in neovascular choroidal morphology after intravitreal bevacizumab injection: prospective trial on 156 eyes throughout 12-month follow-up.
    Costagliola C; Semeraro F; Cipollone U; Rinaldi M; della Corte M; Romano MR
    Graefes Arch Clin Exp Ophthalmol; 2009 Aug; 247(8):1031-7. PubMed ID: 19404665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
    Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
    Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor.
    Wakusawa R; Abe T; Sato H; Sonoda H; Sato M; Mitsuda Y; Takakura T; Fukushima T; Onami H; Nagai N; Ishikawa Y; Nishida K; Sato Y
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3272-80. PubMed ID: 21345982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective comparison of low-fluence photodynamic therapy combined with intravitreal bevacizumab versus bevacizumab monotherapy for choroidal neovascularization in age-related macular degeneration.
    Datseris I; Kontadakis GA; Diamanti R; Datseris I; Pallikaris IG; Theodossiadis P; Tsilimbaris MK
    Semin Ophthalmol; 2015 Mar; 30(2):112-7. PubMed ID: 24117412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
    Seo S; Suh W
    Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Activating Transcription Factor 4 in Murine Choroidal Neovascularization Model.
    Yasuda H; Tanaka M; Nishinaka A; Nakamura S; Shimazawa M; Hara H
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bevacizumab and neovascular age related macular degeneration: pathogenesis and treatment.
    El-Mollayess GM; Noureddine BN; Bashshur ZF
    Semin Ophthalmol; 2011 May; 26(3):69-76. PubMed ID: 21609219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
    Lee JY; Chung H; Kim HC
    Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of foveal microstructural changes with vision after anti-vascular endothelial growth factor therapy in age-related macular degeneration.
    Shin HJ; Chung H; Kim HC
    Retina; 2013 May; 33(5):964-70. PubMed ID: 23348865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal ranibizumab and bevacizumab therapy for choroidal neovascularization in age-related macular degeneration with extensive pre-existing geographic atrophy.
    Amaro MH; Roller AB
    Arq Bras Oftalmol; 2012; 75(4):273-6. PubMed ID: 23258660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of changes in choroidal neovascularization secondary to age-related macular degeneration after anti-VEGF therapy using spectral domain optical coherence tomography.
    You JY; Chung H; Kim HC
    Curr Eye Res; 2012 May; 37(5):438-45. PubMed ID: 22510011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeated retinal photocoagulation in monkeys for the optimization of a laser-induced choroidal neovascularization model.
    Lin X; Wang Q; He M
    Exp Eye Res; 2019 Jul; 184():1-7. PubMed ID: 30928489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal ranibizumab and bevacizumab for the treatment of nonsubfoveal choroidal neovascularization in age-related macular degeneration.
    Roller AB; Amaro MH
    Arq Bras Oftalmol; 2009; 72(5):677-81. PubMed ID: 20027409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors.
    Veritti D; Sarao V; Lanzetta P
    J Ocul Pharmacol Ther; 2013 May; 29(4):437-41. PubMed ID: 23215753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
    Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():42-9. PubMed ID: 19032681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β2-Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression.
    Lavine JA; Farnoodian M; Wang S; Darjatmoko SR; Wright LS; Gamm DM; Ip MS; Sorenson CM; Sheibani N
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):299-308. PubMed ID: 28114591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-vascular Endothelial Growth Factor Antibody Limits the Vascular Leakage and Decreases Subretinal Fibrosis in a Cynomolgus Monkey Choroidal Neovascularization Model.
    Inagaki S; Shimazawa M; Hamaguchi K; Otsu W; Araki T; Sasaki Y; Numata Y; Tsusaki H; Hara H
    Curr Neurovasc Res; 2020; 17(4):420-428. PubMed ID: 32445455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal tanibirumab, a fully human monoclonal antibody against vascular endothelial growth factor receptor 2, partially suppresses and regresses laser-induced choroidal neovascularization in a rat model.
    Kim J; Kim TE; Kim JA; Yun JH; Sohn S; Shim SR; Lee SH; Kim SJ
    J Ocul Pharmacol Ther; 2014 Dec; 30(10):847-53. PubMed ID: 25188901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous injection of l-aspartic acid β-hydroxamate attenuates choroidal neovascularization via anti-VEGF and anti-inflammation.
    Wu M; Liu Y; Zhang H; Lian M; Chen J; Jiang H; Xu Y; Shan G; Wu S
    Exp Eye Res; 2019 May; 182():93-100. PubMed ID: 30917905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).
    Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU
    Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1273-80. PubMed ID: 17333238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.